BHQ is a selective inhibitor of sarco-endoplasmic reticulum Ca2+-ATPase (SERCA).

EN6 covalently targets cysteine 277 in the ATP6V1A subunit of the lysosomal the vacuolar H+ ATPase (v-ATPase). It is a small-molecule in vivo activator of autophagy.

AZD0865 inhibits gastric H+,K+-ATPase by K+-competitive binding.

KM91104 is a specific v-ATPase inhibitor. It specifically targets the interaction between v-ATPase subunit a3 and subunit B2.

Thapsigargin is a naturally occurring tumor promoter derived from the plant Thapsia garganica. Potent inhibitor of sarco-endoplasmic reticulum Ca2+-ATPases. Causes ER stress; can be used to induce autophagy in mammalian cells.

Esomeprazole is a proton-pump inhibitor which reduces stomach acid.

BTB06584 is an IF1-dependent selective inhibitor of the mitochondrial F1Fo-ATPase.

Chebulinic acid is a potent natural inhibitor of M. tuberculosis DNA gyrase, also can inhibit SMAD-3 phosphorylation and H+ K+-ATPase activity.

SCH 28080 is an inhibitor of H+, K+-ATPase with IC50 of 20 nM.

Diphyllin, a natural arylnaphthalene, is potent inhibitor of vacuolar H(+)-ATPase (V-ATPase) that inhibits lysosomal acidification in osteoclasts.

Sodium orthovanadate is an alkaline phosphatase and (Na,K)-ATPase inhibitor with IC50 of 10 μM.

CDN1163 is an allosteric sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) activator that improves Ca2+ homeostasis. CDN1163 attenuates diabetes and metabolic disorders.

FCCP is a potent uncoupler of oxidative phosphorylation in mitochondria that disrupts ATP synthesis by transporting protons across cell membranes.

(-)-Blebbistatin is a cell-permeable inhibitor for non muscle myosin II ATPase with IC50 of ~2 μM in cell-free assays, does not inhibit myosin light chain kinase, inhibits contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly.

Ciclopirox Olamine is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses.

Diacetyl Monoxime is an inhibitor of skeletal muscle myosin-II.

Esomeprazole sodium, the sodium salt of esomeprazole which has the effect of reducing gastric acid secretion.

Ilaprazole inhibited TOPK activities with high affinity and selectivity.

Omecamtiv mecarbil is a selective sarcomere-directed cardiac myosin activator with an EC50 of 0.6 μM.